Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma
Xiaoyu Liu,Qianqian Du,Caiping Tian,Mei Tang,Yingjun Jiang,Yong Wang,Yang Cao,Zhe Wang,Zhenwei Wang,Jing Yang,Yan Li,Xiaozhen Jiao,Ping Xie
DOI: https://doi.org/10.1016/j.bioorg.2020.104536
IF: 5.307
2021-02-01
Bioorganic Chemistry
Abstract:<p>Caffeic acid phenethyl ester (CAPE), a bioactive component extracted from propolis of honeybee hives, can inhibit hepatocellular carcinoma (HCC). In order to explore more stable CAPE derivatives, 25 compounds were designed, synthesized, and pharmacologically assessed in vitro and in vivo as anti-tumor agents in HCC. Compounds <strong>8d</strong>, <strong>8f</strong>, <strong>8l</strong>, <strong>8j</strong>, and <strong>8k</strong> showed favorable antiproliferative activity than other compounds including CAPE in the HCC cell lines. Based on the result of QTRP (Quantitative Thiol Reactivity Profiling), epidermal growth factor receptor (EGFR) and C-terminal Src kinase (CSK) were supposed to the targets of <strong>8f</strong>, which was confirmed by binding mode analysis. Furthermore, compounds <strong>8f</strong>, <strong>8l, 8j</strong>, <strong>8k</strong>, <strong>8g</strong>, and <strong>8h</strong> showed potent inhibitory effects against both CSK and EGFR than other derivatives in an ADP-Glo™ kinase assay. The representative compound, <strong>8f</strong>, potently inhibited various tumor growth in murine model including murine hepatocellular carcinoma H22, meanwhile downregulating the EGFR/AKT pathway and enhancing T cell proliferation through inhibition of CSK. Metabolic stability in vitro suggested <strong>8f</strong> and <strong>8k</strong> were more stable in mouse plasma than CAPE and susceptible to metabolism in liver microsomes. The overall excellent profile of compound <strong>8f</strong> makes it a potential candidate for further preclinical investigation.</p>
biochemistry & molecular biology,chemistry, organic